A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: Results from a multicenter retrospective cohort study

Max J. Gordon, Andrea Sitlinger, Tareq Salous, Hamood Alqahtani, Michael Churnetski, Xavier Rivera, Paul Wisniewski, Jonathon Cohen, Krish Patel, Mayzar Shadman, Michael Choi, Brian Hill, Deborah Stephens, Daniel Persky, Danielle Brander, Alexey V. Danilov

Research output: Contribution to journalLetter

Original languageEnglish (US)
Article number106302
JournalLeukemia Research
Volume89
DOIs
StatePublished - Feb 2020

Keywords

  • Chronic lymphocytic leukemia
  • Ibrutinib
  • Prognostic index

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Gordon, M. J., Sitlinger, A., Salous, T., Alqahtani, H., Churnetski, M., Rivera, X., Wisniewski, P., Cohen, J., Patel, K., Shadman, M., Choi, M., Hill, B., Stephens, D., Persky, D., Brander, D., & Danilov, A. V. (2020). A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: Results from a multicenter retrospective cohort study. Leukemia Research, 89, [106302]. https://doi.org/10.1016/j.leukres.2020.106302